Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929006 · ClinicalTrials.gov registry record · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
A Early Phase 1 study of Puberty and Hyperandrogenism, sponsored by University of Virginia.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00929006 is a Early Phase 1 study of Puberty and Hyperandrogenism that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 36 participants, below the 93-participant average among 8 other Puberty trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00929006, a Early Phase 1 study of Puberty and Hyperandrogenism, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is two-fold. (1) We will determine if in mid- to late pubertal girls without hyperandrogenism (HA), progesterone (P4) acutely reduces waking luteinizing hormone (LH) frequency to a greater extent than sleep-associated LH frequency. (2) We will determine if in mid- to late pubertal girls with HA, P4 will acutely suppress waking LH frequency to a lesser degree than it does in girls without HA.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Micronized progesterone suspension
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-06 |
| Est. Completion | 2025-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929006
The ClinicalTrials.gov registry entry for NCT00929006 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 8 other Puberty trials with a reported enrollment target (61% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Puberty appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00929006 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00929006 about?
NCT00929006 is a clinical study titled "Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism". The purpose of this study is two-fold. (1) We will determine if in mid- to late pubertal girls without hyperandrogenism (HA), progesterone (P4) acutely reduces waking luteinizing hormone (LH) frequency to a greater extent than sleep-associated LH frequency. (2) We will determine if in mid- to late p...
What is the current status of trial NCT00929006?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2008-06. Estimated completion is 2025-12-01.
What conditions does trial NCT00929006 study?
This clinical trial studies the following conditions: Puberty, Hyperandrogenism.
What interventions are being tested in trial NCT00929006?
The interventions under investigation include: Placebo (DRUG), Micronized progesterone suspension (DRUG).
Who is sponsoring clinical trial NCT00929006?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00929006 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Puberty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
RECRUITING · Early Phase 1
-
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
RECRUITING · Early Phase 1
-
Investigating the Impact of Obesity on Pubertal Development in Girls
RECRUITING
-
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
Ovarian Morphology in Girls
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.